https://www.mychesco.com/a/news/regional/promising-phase-2-trial-results-cti-1601-shows-increases-in-fxn-levels-in-friedreichs-ataxia-participants-says-larimar-therapeutics/
Promising Phase 2 Trial Results: CTI-1601 Shows Increases in FXN Levels in Friedreich's Ataxia Participants, Says Larimar Therapeutics